Stockreport

CytomX Therapeutics (CTMX): Assessing Valuation After Phase 1 CX-801 Data Preview at SITC Annual Meeting [Yahoo! Finance]

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com
PDF The company will share early data from its Phase 1 study of CX-801 in advanced melanoma patients. See our latest analysis for CytomX Therapeutics. After years of mut [Read more]